Regulatory guidance and validation science for digital endpoints are solid. The real barrier is cross-functional execution – and the cost of waiting is compounding.
- Sites Are Building Their Own Tech – SCRS On What That Means
- Human-In-The-Loop In AI Validation And Control: From Principle To Practice
- When The System Breaks, Who Pays? SCRS On Site Tech Gaps
- HTA, Digital Twins, And Building Clinical Tech That Lasts
- Real-World Evidence And Wearables Are Reshaping Trial Tech
- Navigating Elsa's AI Transition: Practical Guidance To Safeguard Confidential Information (Part 3)
- HEOR, AI, And The Future Of Clinical Trial Technology
- AI Amplifies Capabilities But Also Risks: Learn The Legal Consequences Of AI In Clinical Research
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
The Power Of Site Enablement Platforms As An Insurance Policy
Delve into the pivotal role played by this Site Enablement Platform in upholding business continuity for clinical trials.
-
Collecting Trial Data From Patients In Remote Areas
Learn how mobile technology can promote trial inclusivity and diversity, and its potential to revolutionize clinical studies, making them more accessible and representative of the population.
-
A Beginner's Guide To Compliant Electronic Source Data Capture
With today’s complex trials, the expectation of gathering faster results in an increasingly decentralized environment is only increasing, imploring investigators to implement electronic source data capture systems. How can researchers ensure this is done correctly? Leveraging the right technology to standardize a compliant process for source data capture is a proven way to reach these goals.
-
Why Portable 6-Lead Devices Are The Future Of Cardiac Monitoring
Explore advanced technologies that offer a remote solution to maintain rigorous standards for ECG assessment while adapting your trial to have a more patient-centered design.
-
Implementing ICH E6 (R3) In A Risk Averse Culture
Get several pointers on how to facilitate a transition to an agile, multi-faceted, and continuous risk and issue management approach aligned with the Statistical Analysis Plan.
-
Accelerating Your New Therapies Path To Market With Automation
Automation has become an essential tool for addressing the inefficiencies in traditional clinical trial methodologies, enabling trial teams to instead concentrate on critical tasks such as patient care.
-
Demystifying AI: The Fundamentals And Applications In Drug Development
Explore the history of AI, gain clarity on key concepts, address common questions, and discover its transformative role in drug development, with insights into its current and future impact on the industry.
-
Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial
Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
-
Executing Concurrent Decentralized RCTs And RWE At Scale
See how a team of four managed data for 40 peer-reviewed studies and 200,000 participants.
-
Why Data Integrity Still Matters — Even As Clinical Trials Evolve
Data integrity remains essential for compliance and patient safety. Learn strategies to maintain accuracy and reliability as clinical research evolves toward more connected, technology-driven models.
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- Sites Are Building Their Own Tech – SCRS On What That Means
- When The System Breaks, Who Pays? SCRS On Site Tech Gaps
- HTA, Digital Twins, And Building Clinical Tech That Lasts
RECENT NEWSLETTERS
- 05.07.26 -- How AI, ICH E6(R3) & RWD Are Reshaping Clinical Trials
- 05.02.26 -- Best Of April: AI In Clinical Trials — What Working
- 04.30.26 -- AI, RWE & Predictive Analytics Are Reshaping Trials
- 04.23.26 -- Smarter Trials Start Here: Data Quality, AI & Infrastructure Insights
- 04.16.26 -- 5 eTMF Questions, Agentic AI's Real Impact On Clinical Trials & More